CEIIX | VMVAX | CEIIX / VMVAX | |
Total Expense Ratio | 1.12 | 0.07 | 1,600% |
Annual Report Gross Expense Ratio | 1.24 | 0.07 | 1,771% |
Fund Existence | 2 years | 14 years | - |
Gain YTD | -6.733 | -3.677 | 183% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 161M | 29.9B | 1% |
Annual Yield % from dividends | 3.85 | 2.33 | 166% |
Returns for 1 year | -1.91 | 4.74 | -40% |
Returns for 3 years | N/A | 10.29 | - |
Returns for 5 years | N/A | 78.07 | - |
Returns for 10 years | N/A | 71.44 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EMXC | 56.74 | 0.20 | +0.35% |
iShares MSCI Emerging Mkts ex China ETF | |||
SPHB | 79.17 | N/A | N/A |
Invesco S&P 500® High Beta ETF | |||
TPHE | 24.41 | -0.06 | -0.25% |
Timothy Plan High Dividend Stock Enh ETF | |||
FAB | 75.57 | -0.28 | -0.37% |
First Trust Multi Cap Val AlphaDEX® ETF | |||
SCHQ | 32.09 | -0.42 | -1.29% |
Schwab Long-Term US Treasury ETF |